[Relation of hydantoin preparations to the development of disseminated lupus erythematosus]. 1965

J Strejcek, and M Hrbková

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006827 Hydantoins Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS. Hydantoin,Imidazolidine-2,4-Diones,Imidazolidine 2,4 Diones

Related Publications

J Strejcek, and M Hrbková
January 1972, Annales immunologiae Hungaricae,
J Strejcek, and M Hrbková
October 1957, A.M.A. archives of pathology,
J Strejcek, and M Hrbková
November 1984, Revue de l'infirmiere,
J Strejcek, and M Hrbková
October 1962, Vie medicale (Paris, France : 1920),
J Strejcek, and M Hrbková
February 1949, American journal of clinical pathology,
J Strejcek, and M Hrbková
March 1948, Archives of dermatology and syphilology,
J Strejcek, and M Hrbková
July 1971, Munca sanitara,
J Strejcek, and M Hrbková
October 1954, British medical journal,
Copied contents to your clipboard!